2018 What You Must Know to Succeed? - Early Phase Clinical Development Workshop

Overview

Early phase clinical development is essential to the overall drug R&D. The value of R&D won’t be maximized without higher success rates of clinical trials and lower costs. Theaking correct strategies and tactics are the guarantee of a successful drug development, which is you must know. This course, beginning with the macro strategies of the clinical design, taking the examples of oncology/non-oncology clinical trials, explains the phase I, statistics and the first-in-human (FIH), as well as the Proof of Concept (PoC) to transition to phase III, and finally gives tactical guidance on the operational level.

Program Committee

Min Wang Irwin, MD, PhD Venture Partner
Qiming Weichuang Venture Capital Management (Shanghai) Co. Ltd., China
George LIU Head of Early Development and Scientific Operation
Harbour Biomed, China
Jielai Xia, PhD Director, Department of Medical Statistics
Air Force Military Medical University, China

Digital Learning Catalog

Download

Have an account?

2018 What You Must Know to Succeed? - Early Phase Clinical Development Workshop

Overview

Who should attend?

Learning objectives

Program Committee

Digital Learning Catalog

Be informed and stay engaged.